Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Kanebo reports novel cell adhesion inhibitors

July 17, 1997

Dual mechanism of action for antiatherosclerotic compound Org-13061

July 16, 1997

Eclipse submits PMA for Transmyocardial Revascularization procedure

July 15, 1997

Potent and selective M2 receptor antagonist discovered by Yamanouchi

July 15, 1997

Mibefradil more effective than extended-release diltiazem in hypertension

July 15, 1997

MMP inhibitors from Warner-Lambert

July 15, 1997

Rutaecarpine, a vasorelaxant component of an herbal drug

July 15, 1997

More on aspirin in cardiovascular medicine

July 14, 1997

Knoll receives FDA approval to market Mavik for new indication

July 14, 1997

U.S. patent covers protease inhibitors from Sparta and Univ. of Pennsylvania

July 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...